PGLS and breast carcinoma: For example, the expression of glucose-6-phosphate dehydrogenase (G6PD) and 6-phosphogluconolactonase (6PGL) were elevated, implying a more activated PPP in HER2 subtype than other subtypes of breast cancer (17).